These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 3035246

  • 1. Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts.
    Erice A, Jordan MC, Chace BA, Fletcher C, Chinnock BJ, Balfour HH.
    JAMA; 1987 Jun 12; 257(22):3082-7. PubMed ID: 3035246
    [Abstract] [Full Text] [Related]

  • 2. Ganciclovir therapy for cytomegalovirus infections in recipients of bone marrow transplants and other immunosuppressed patients.
    Winston DJ, Ho WG, Bartoni K, Holland GN, Mitsuyasu RT, Gale RP, Busuttil RW, Champlin RE.
    Rev Infect Dis; 1988 Jun 12; 10 Suppl 3():S547-53. PubMed ID: 2847292
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
    Rubin RH, Kemmerly SA, Conti D, Doran M, Murray BM, Neylan JF, Pappas C, Pitts D, Avery R, Pavlakis M, Del Busto R, DeNofrio D, Blumberg EA, Schoenfeld DA, Donohue T, Fisher SA, Fishman JA.
    Transpl Infect Dis; 2000 Sep 12; 2(3):112-7. PubMed ID: 11429021
    [Abstract] [Full Text] [Related]

  • 6. Ganciclovir therapy for cytomegalovirus disease associated with renal transplants.
    Snydman DR.
    Rev Infect Dis; 1988 Sep 12; 10 Suppl 3():S554-62. PubMed ID: 2847293
    [Abstract] [Full Text] [Related]

  • 7. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
    Canpolat C, Culbert S, Gardner M, Whimbey E, Tarrand J, Chan KW.
    Bone Marrow Transplant; 1996 Apr 12; 17(4):589-93. PubMed ID: 8722360
    [Abstract] [Full Text] [Related]

  • 8. Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy.
    Turgeon N, Fishman JA, Basgoz N, Tolkoff-Rubin NE, Doran M, Cosimi AB, Rubin RH.
    Transplantation; 1998 Dec 27; 66(12):1780-6. PubMed ID: 9884276
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevention of recurrent cytomegalovirus disease in renal and liver transplant recipients: effect of oral ganciclovir.
    Turgeon N, Fishman JA, Doran M, Basgoz N, Tolkoff-Rubin NE, Cosimi AB, Rubin RH.
    Transpl Infect Dis; 2000 Mar 27; 2(1):2-10. PubMed ID: 11429003
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients.
    Buhles WC, Mastre BJ, Tinker AJ, Strand V, Koretz SH.
    Rev Infect Dis; 1988 Mar 27; 10 Suppl 3():S495-506. PubMed ID: 2847286
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.
    Winston DJ, Busuttil RW.
    Transplantation; 2003 Jan 27; 75(2):229-33. PubMed ID: 12548129
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment and prophylaxis of cytomegalovirus disease.
    Levinson ML, Jacobson PA.
    Pharmacotherapy; 1992 Jan 27; 12(4):300-18. PubMed ID: 1325636
    [Abstract] [Full Text] [Related]

  • 17. Ganciclovir therapy of severe cytomegalovirus infections in solid-organ transplant recipients.
    Harbison MA, De Girolami PC, Jenkins RL, Hammer SM.
    Transplantation; 1988 Jul 27; 46(1):82-8. PubMed ID: 2839916
    [Abstract] [Full Text] [Related]

  • 18. Ganciclovir and hyperimmunoglobulin for treating cytomegalovirus infection in bone marrow transplant recipients.
    Aulitzky WE, Tilg H, Niederwieser D, Hackl M, Meister B, Huber C.
    J Infect Dis; 1988 Aug 27; 158(2):488-9. PubMed ID: 2841384
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of ganciclovir for cytomegalovirus disease.
    Fletcher CV, Balfour HH.
    DICP; 1989 Jan 27; 23(1):5-12. PubMed ID: 2541566
    [Abstract] [Full Text] [Related]

  • 20. Successful treatment with ganciclovir of disseminated cytomegalovirus infection after liver transplantation.
    Stein DS, Verano AS, Levandowski RA.
    Am J Gastroenterol; 1988 Jun 27; 83(6):684-6. PubMed ID: 2837082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.